发明名称 |
EXPRESSION PROFILES ASSOCIATED WITH IRINOTECAN TREATMENT |
摘要 |
The present invention includes gene and protein expression profiles indicative of whether a cancer patient is likely to respond to treatment with irinotecan. By identifying such responsiveness, a treatment provider may determine in advance those patients who would benefit from such treatment, as well as identify alternative therapies for non-responders. The present invention further provide methods of using the gene and/or protein expression profiles and assays for identifying the presence of a gene and/or protein expression profile in a patient sample. |
申请公布号 |
WO2008073177(A3) |
申请公布日期 |
2008.11.06 |
申请号 |
WO2007US20498 |
申请日期 |
2007.09.21 |
申请人 |
NUCLEA BIOMARKERS, LLC;MURACA, PATRICK, J. |
发明人 |
MURACA, PATRICK, J. |
分类号 |
C07H21/04 |
主分类号 |
C07H21/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|